Curis | CRIS - Pre Tax Profit


Curis reported $19.36M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 3.91B 1.28B Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Incyte USD 343.6M 46.34M Mar/2026
Merck USD 3.42B 3.32B Dec/2025
Novartis USD 3.84B 802M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Takeda JPY -52.48B 186.34B Mar/2026
TG Therapeutics USD 20.36M 24.73M Mar/2026
Verastem USD -32.92M 944K Dec/2025
Xoma USD 15.98M 24.58M Jun/2024